Overview

DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the different dose of DMTA07 (DM) combine with amlodipine in the treatment of mild to moderate essential hypertension, and to define the optimized dose of DM in the combination therapy.
Phase:
Phase 2
Details
Lead Sponsor:
TSH Biopharm Corporation Limited
Treatments:
Amlodipine